DIS News 86.23 07/28/2014 04:57:15 Walt Disney Company (DIS)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Walt Disney Company (DIS) 86.23 $DIS


'Lucy' tops 'Hercules' with $44M at box office
By RYAN NAKASHIMA - AP - Sun Jul 27, 1:38PM CDT
LOS ANGELES (AP) — Luc Besson's "Lucy" proved mind can overpower muscle, topping a remake of "Hercules" by director Brett Ratner at the box office on the weekend.

2 Assets Disney Can't Live Without!
Daniel Jones, The Motley Fool - Motley Fool - Sun Jul 27, 9:09AM CDT
Source: Disney As one of the largest entertainment-oriented businesses in the world, The Walt Disney Company has created a large economic moat for itself. In doing so, the business has seen its sales and profits go through the roof,...

Comic-Con 2014: 3 Business Questions Every Investor Needs Answered
Tim Beyers, Steve Symington, and Leo Sun, The Motley Fool - Motley Fool - Sat Jul 26, 4:04PM CDT
With the Big Two presenting, Saturday is sure to be the biggest day of Comic-Con 2014. Credit: SDCC. Comic-Con 2014 is expected to add $178 million to the San Diego economy. Hollywood has much more than that on the line. Every major studio is...

After taking Investors On A Wild Ride, Can Six Flags Redeem Itself?
Daniel Jones, The Motley Fool - Motley Fool - Sat Jul 26, 9:00AM CDT
Source: Six Flags.  After announcing revenue and earnings results for the second quarter of its 2014 fiscal year on July 21, shares of Six Flags Entertainment dropped 4% before recovering a bit on Jul. 22. In spite of seeing a nice uptick in...

Final Glance: Media companies
AP - Fri Jul 25, 5:12PM CDT
NEW YORK (AP) — Shares of some top media companies were mixed at the close of trading:

Disney to Benefit from Marvel's Expansion into TV - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 5:10PM CDT
Disney's (DIS) Marvel forayed into the world of television last year with "Agents of SHIELD."

Will Gotham Be the Superhero to Save Fox's Falling Ratings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 25, 4:30PM CDT
Fox is witnessing declining prime time ratings and expects its new show Gotham to turnaround things.

Disney's Sequel Nightmare Is a Win for Twenty-First Century Fox and Comcast!
Daniel Jones, The Motley Fool - Motley Fool - Fri Jul 25, 4:00PM CDT
Source: Twenty-First Century Fox The weekend ending July 20th was somewhat mixed for movies produced by The Walt Disney Company , Twenty-First Century Fox , and Comcast . For the three-day period, Disney's Planes: Fire & Rescue saw a...

Midday Glance: Media companies
AP - Fri Jul 25, 12:42PM CDT
NEW YORK (AP) — Shares of some top media companies are mixed at 1 p.m.:

Early Glance: Media companies
AP - Fri Jul 25, 9:22AM CDT
NEW YORK (AP) — Shares of some top media companies are mixed at 10 a.m.:

Disney and CBS Can't Keep Up with Comcast!
Daniel Jones, The Motley Fool - Motley Fool - Fri Jul 25, 8:10AM CDT
Source: Comcast Before the market opened on July 22, Comcast , the world's largest cable operator, reported revenue and earnings for the second quarter of its 2014 fiscal year. In spite of missing on the top line, management's announcement that...

Mattel Faces Pressure Amid Slowing Barbie Sales
Daniel James, The Motley Fool - Motley Fool - Fri Jul 25, 8:00AM CDT
For years, Barbie was the blue-eyed, blonde representative of the US toy industry. As an iconic figure, although she has changed over the years, her popularity remained beyond question for a long time. Now, things seem to be changing. The most...

Time Warner, Bright House to carry SEC Network
AP - Fri Jul 25, 5:59AM CDT
BIRMINGHAM, Ala. (AP) — Time Warner Cable and Bright House Networks have reached deals with ESPN to carry the SEC Network.

Dow Flat; Disney Gains on Comic-Con 2014 as Zoe's Kitchen Heats Up
John Divine, The Motley Fool - Motley Fool - Thu Jul 24, 5:52PM CDT
Ignoring increasingly tumultuous geopolitical tensions, the Dow Jones Industrial Average was nearly unmoved on Thursday, as investors instead chose to focus on corporate earnings and fresh economic data. The data was mixed, as jobless claims...

DICK'S Sporting Lays Off 400+ PGA Pro to Reduce Golf Exposure - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 24, 5:20PM CDT
The Wall Street Journal reported that DICK'S Sporting Goods Inc. (DKS) lays off over 400 PGA professionals to reduce exposure in golf business.

Mack Brown to serve as ABC studio analyst
AP - Thu Jul 24, 12:49PM CDT
BRISTOL, Conn. (AP) — Former Texas coach Mack Brown will serve as a studio analyst for college football games on ABC.

Disney and USAA Offer 'Veterans Institute' Workshop in San Antonio to Encourage Hiring of Military Veterans
Business Wire - Thu Jul 24, 11:00AM CDT
The Walt Disney Company (NYSE: DIS) and USAA will bring Disney's Veterans Institute to San Antonio on Aug. 19, with a daylong seminar designed to inspire companies in the region to build their own veteran hiring programs.

Comic-Con 2014: Will Disney and Time Warner Continue to Cash In?
Tim Beyers, The Motley Fool - Motley Fool - Thu Jul 24, 10:59AM CDT
Enormous lines and big reveals make Comic-Con what it is. Credit: SDCC. Over 150,000 deep-pocketed nerds descended on San Diego Thursday morning, kicking off Comic-Con 2014 and a weekend war to win the hearts and minds of fans. No two companies...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 209

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 222

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Marina Genova Joins SEA Index to Promote Sustainable Yachting

Updated Category News Views 173

Marina Genova Enters SEA Index as an Institutional Member Recently, the Superyacht Eco Association – SEA Index welcomed Marina Genova, a prominent destination for yachting in the Mediterranean, as an Institutional Member. This collaboration signifies a crucial step in the yachting community's commitment to integrating environmental sustainability into its operations....

Continue Reading
Warren Buffett’s Top 2025 Stock Picks You Need to Know

Updated Category News Views 2610

Warren Buffett’s Strategic Stock Investments for 2025 Warren Buffett, the Oracle of Omaha, is known for his keen investment strategies and ability to recognize value in both good and bad market conditions. In the current volatile landscape, his portfolio continues to evolve, with some old favorites and new bets that show his forward-thinking approach. As we look ahead...

Continue Reading
Graves' Ophthalmopathy Market Surges with New Therapies

Updated Category News Views 50

Unexpected Growth in Graves' Ophthalmopathy Market Over the next decade, we're seeing the Graves' ophthalmopathy market gearing up for some serious growth, clocking in at a hefty compound annual growth rate of 9%. A good chunk of this is thanks to Viridian's newest player, LUMVOA, getting the green light, sending competitors scrambling and pushing innovation into...

Continue Reading
Tris Pharma Launches ONYDA XR: A New ADHD Liquid Solution

Updated Category News Views 210

So back in 2024, Tris Pharma rolled out ONYDA™ XR—this liquid medication aimed at tackling ADHD in kids six and older. It was billed as a game changer, especially since the FDA gave it the green light. The desks were buzzing about this first-of-its-kind non-stimulant therapy, positioning it like a golden ticket for parents tired of conventional stimulants that might...

Continue Reading
JPMorgan Updates Price Target for W. P. Carey to $70

Updated Category News Views 242

JPMorgan Boosts W. P. Carey's Price Target Recently, JPMorgan has refreshed its price target for W. P. Carey & Co. (NYSE: WPC), raising it from $68.00 to $70.00, while retaining an Overweight rating on the stock. This adjustment comes ahead of the company’s third-quarter earnings announcement, indicating the firm's confidence in W. P. Carey’s future potential....

Continue Reading